AMYLYX PHARMACEUTICALS UK LIMITED
Overview
| Company Name | AMYLYX PHARMACEUTICALS UK LIMITED |
|---|---|
| Company Status | Active |
| Legal Form | Private limited company |
| Company Number | 14766294 |
| Jurisdiction | England/Wales |
| Date of Creation |
Summary
| Has Super Secure PSCs | No |
|---|---|
| Has Charges | No |
| Has Insolvency History | No |
| Registered Office is in Dispute | No |
What is the purpose of AMYLYX PHARMACEUTICALS UK LIMITED?
- Manufacture of basic pharmaceutical products (21100) / Manufacturing
Where is AMYLYX PHARMACEUTICALS UK LIMITED located?
| Registered Office Address | 21 Holborn Viaduct EC1A 2DY London United Kingdom |
|---|---|
| Undeliverable Registered Office Address | No |
What are the latest accounts for AMYLYX PHARMACEUTICALS UK LIMITED?
| Overdue | No |
|---|---|
| Next Accounts | |
| Next Accounts Period End On | Dec 31, 2024 |
| Next Accounts Due On | Sep 30, 2025 |
| Last Accounts | |
| Last Accounts Made Up To | Dec 31, 2023 |
What is the status of the latest confirmation statement for AMYLYX PHARMACEUTICALS UK LIMITED?
| Last Confirmation Statement Made Up To | Mar 28, 2025 |
|---|---|
| Next Confirmation Statement Due | Apr 11, 2025 |
| Last Confirmation Statement | |
| Next Confirmation Statement Made Up To | Mar 28, 2024 |
| Overdue | No |
What are the latest filings for AMYLYX PHARMACEUTICALS UK LIMITED?
| Date | Description | Document | Type | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accounts for a small company made up to Dec 31, 2023 | 21 pages | AA | ||||||||||
Appointment of James Matthew Frates as a director on May 31, 2024 | 2 pages | AP01 | ||||||||||
Termination of appointment of Stephanie Hoffmann as a director on May 31, 2024 | 1 pages | TM01 | ||||||||||
Termination of appointment of Thomas Biet as a director on May 31, 2024 | 1 pages | TM01 | ||||||||||
Appointment of Thomas Joseph Holmes as a director on May 31, 2024 | 2 pages | AP01 | ||||||||||
Confirmation statement made on Mar 28, 2024 with updates | 5 pages | CS01 | ||||||||||
Current accounting period shortened from Mar 31, 2024 to Dec 31, 2023 | 1 pages | AA01 | ||||||||||
Incorporation | 29 pages | NEWINC | ||||||||||
| ||||||||||||
Who are the officers of AMYLYX PHARMACEUTICALS UK LIMITED?
| Name | Appointed On | Resigned On | Role | Address | Company Identification | Country of Residence | Nationality | Date of Birth | Occupation | Number | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SISEC LIMITED | Secretary | EC1A 2DY London 21 Holborn Viaduct |
| 38545840001 | ||||||||||
| FRATES, James Matthew | Director | EC1A 2DY London 21 Holborn Viaduct United Kingdom | United States | American | Chief Financial Officer | 323666960001 | ||||||||
| HOLMES, Thomas Joseph | Director | EC1A 2DY London 21 Holborn Viaduct United Kingdom | United States | American | Company Director | 323588090001 | ||||||||
| BIET, Thomas | Director | EC1A 2DY London 21 Holborn Viaduct United Kingdom | Switzerland | Swiss | Emea Finance Head | 307297890001 | ||||||||
| HOFFMANN, Stephanie | Director | EC1A 2DY London 21 Holborn Viaduct United Kingdom | Belgium | Belgian | Emea General Manager | 307297880001 |
Who are the persons with significant control of AMYLYX PHARMACEUTICALS UK LIMITED?
| Name | Notified On | Address | Ceased | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | Mar 29, 2023 | MA 02141 Cambridge 43 Thorndike Street United States | No | ||||||||||
| |||||||||||||
Natures of Control
| |||||||||||||
Data Source
- UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings. - license: CC0